Postherpetic Neuralgia
📧 Sign up to get email alerts when something new happens for Postherpetic Neuralgia.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2011-04-26FDA Approved: PREGABALIN — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for pregabalin submitted by Mylan Pharmaceuticals Inc., updating the regulatory status of the produc…
-
CLINICAL_TRIALS trial_result · 2011-04-14Clinical Trial Update: Study to Find Out if Therapy With the Drug Pregabalin Relieves Pain During Shingles Compared With Placebo [Phase 2]
A Phase 2 study evaluating pregabalin versus placebo for pain relief in herpes zoster (shingles) and postherpetic neuralgia has been termina…
-
CLINICAL_TRIALS trial_result · 2011-04-07Clinical Trial Update: A Trial Assessing The Long Term Safety And Tolerability Of [S,S]-Reboxetine In Patients With Post-Shingles Pain. [Phase 2]
Pfizer conducted a Phase 2 study to evaluate the long-term safety and tolerability of S,S-Reboxetine in patients with post-shingles pain, bu…
-
FDA approval · 2011-04-06FDA Approved: HORIZANT — Original Application (Azurity Pharmaceuticals, Inc. (formerly Arbor Pharmaceuticals))
FDA approved Horizant (gabapentin enacarbil) under an original application for the treatment of restless legs syndrome in adults and posther…
-
FDA approval · 2011-03-30FDA Approved: GABAPENTIN — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for gabapentin from Sun Pharmaceutical Industries, Inc. (ANDA077242), confirming regulatory approval…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2011-03-30FDA Approved: GABAPENTIN — Supplemental Application (Amneal Pharmaceuticals LLC)
FDA approved a supplemental application for gabapentin from Amneal Pharmaceuticals LLC. This entry reflects a supplemental approval of a gen…
-
CLINICAL_TRIALS trial_result · 2011-03-23Clinical Trial Update: Evaluation of the Efficacy, Tolerability and Safety of Etoricoxib (Arcoxia) in Patients With Neuropathic Pain [Phase 4]
Phase 4 study evaluating the efficacy, tolerability and safety of etoricoxib (Arcoxia) in neuropathic pain, including postherpetic neuralgia…
-
FDA approval · 2011-03-01FDA Approved: NEURONTIN — Supplemental Application (Parke-Davis Div of Pfizer Inc)
The FDA approved a supplemental application for Neurontin (gabapentin) from the Parke-Davis Division of Pfizer Inc, resulting in an updated …
-
FDA approval · 2011-02-18FDA Approved: GABAPENTIN — Original Application (BioComp Pharma, Inc.)
FDA approved BioComp Pharma, Inc.'s original application for gabapentin, granting generic status and permission to market the product. Gabap…
-
FDA approval · 2011-02-11FDA Approved: GABAPENTIN — Original Application (Zydus Pharmaceuticals USA Inc.)
FDA approves Zydus Pharmaceuticals USA Inc.'s Gabapentin under an original ANDA, authorizing a generic gabapentin product.
-
FDA approval · 2011-01-28FDA Approved: GRALISE — Original Application (Almatica Pharma LLC)
FDA granted approval for GRALISE (gabapentin) under the original NDA from Almatica Pharma LLC for the treatment of postherpetic neuralgia.
-
FDA approval · 2011-01-10FDA Approved: GABAPENTIN — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for gabapentin from Aurobindo Pharma Limited, marking a supplemental approval for this generic g…
-
FDA approval · 2010-12-17FDA Approved: GABAPENTIN — Original Application (Ascend Laboratories, LLC)
FDA approved Ascend Laboratories, LLC's Original Application for gabapentin (generic), authorizing its use for partial seizures in epilepsy …
-
CLINICAL_TRIALS trial_result · 2010-12-01Clinical Trial Update: Reduction of Postherpetic Neuralgia in Herpes Zoster [NA]
A completed clinical trial studying reduction of postherpetic neuralgia in patients with herpes zoster; the snippet does not provide efficac…
-
CLINICAL_TRIALS research · 2010-08-05Clinical Trial Update: Development of a Bedside Pain Assessment Kit for Postherpetic Neuralgia
This clinical trial update describes the ongoing development of a bedside pain assessment kit for postherpetic neuralgia, sponsored by Analg…
-
CLINICAL_TRIALS research · 2010-07-29Clinical Trial Update: Dose-Finding Study of REN-1654 in Patients With Post-Herpetic Neuralgia [Phase 2]
A Phase 2 dose-finding trial of REN-1654 for post-herpetic neuralgia, sponsored by Renovis, is described as an update.
-
FDA approval · 2010-05-17FDA Approved: GABAPENTIN — Supplemental Application (Amneal Pharmaceuticals LLC)
The FDA approved a supplemental application for gabapentin filed by Amneal Pharmaceuticals LLC.
-
FDA approval · 2010-05-14FDA Approved: GABAPENTIN — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for Gabapentin from Sun Pharmaceutical Industries, Inc.
-
FDA approval · 2010-05-13FDA Approved: GABAPENTIN — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for gabapentin from Actavis Pharma, Inc. under ANDA075350, typically reflecting a label change or fo…
-
FDA approval · 2010-05-13FDA Approved: GABAPENTIN — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA granted supplemental approval for gabapentin submitted by Sun Pharmaceutical Industries, Inc.
-
FDA approval · 2010-04-13FDA Approved: LIDOCAINE — Supplemental Application (Endo USA, Inc.)
The FDA approved a supplemental application for Lidocaine Patch 5% from Endo USA, Inc., expanding the regulatory authorization for this prod…
-
CLINICAL_TRIALS research · 2010-04-12Clinical Trial Update: Effect of Opioids in Neuropathic Pain in Postherpetic Patients [Phase 3]
A Phase 3 clinical trial update examining the effect of opioids on neuropathic pain in patients with postherpetic neuralgia.
-
CLINICAL_TRIALS trial_result · 2010-02-05Clinical Trial Update: Neuropathic Pain Syndrome Patient Study (MK-0000-072) [Phase 1]
A Phase 1 trial of MK-0000-072 sponsored by Merck in patients with various neuropathic conditions; results were posted in 2010.
-
FDA approval · 2010-01-04FDA Approved: PREGABALIN — Original Application (Mylan Pharmaceuticals Inc.)
FDA approved the original application for pregabalin from Mylan Pharmaceuticals, confirming a generic version of the drug.
-
FDA approval · 2009-12-30FDA Approved: GABAPENTIN — Original Application (Exelan Pharmaceuticals, Inc.)
The FDA approves Exelan Pharmaceuticals, Inc.'s original application for gabapentin as a generic product.